Transition Metal Complexes as Anticancer drugs in pharma Industry

Cancer is a dreadful disease and any practical solution in combating this disease is of paramount importance to public health. Cancer patients have burdened by drug induced toxic side effects, and no turned to seek help from the complementary and alternative medicine hoping for a better cure. Inorganic chemotherapy has been considerably boosted in recent years by the discovery and exploitation of Antitumor compounds based on platinum. Some Gold (III) complexes display similar chemistry. Pharmacological activity to cis-platin and its analogues are now the basis of multimillion dollars industry and bring benefit to thousands of cancer patients. Platinum based anticancer drugs induces normal tissue toxicity particularly to the kidneys and thus alternative metal compounds are presently being evaluated in clinical trials.